BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

364 related articles for article (PubMed ID: 30093115)

  • 1. Intraperitoneal injection of MSC-derived exosomes prevent experimental bronchopulmonary dysplasia.
    Braun RK; Chetty C; Balasubramaniam V; Centanni R; Haraldsdottir K; Hematti P; Eldridge MW
    Biochem Biophys Res Commun; 2018 Sep; 503(4):2653-2658. PubMed ID: 30093115
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Effect of Gender on Mesenchymal Stem Cell (MSC) Efficacy in Neonatal Hyperoxia-Induced Lung Injury.
    Sammour I; Somashekar S; Huang J; Batlahally S; Breton M; Valasaki K; Khan A; Wu S; Young KC
    PLoS One; 2016; 11(10):e0164269. PubMed ID: 27711256
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Early gestational mesenchymal stem cell secretome attenuates experimental bronchopulmonary dysplasia in part via exosome-associated factor TSG-6.
    Chaubey S; Thueson S; Ponnalagu D; Alam MA; Gheorghe CP; Aghai Z; Singh H; Bhandari V
    Stem Cell Res Ther; 2018 Jun; 9(1):173. PubMed ID: 29941022
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Stromal derived factor-1 mediates the lung regenerative effects of mesenchymal stem cells in a rodent model of bronchopulmonary dysplasia.
    Reiter J; Drummond S; Sammour I; Huang J; Florea V; Dornas P; Hare JM; Rodrigues CO; Young KC
    Respir Res; 2017 Jul; 18(1):137. PubMed ID: 28701189
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mesenchymal Stromal Cell Exosomes Ameliorate Experimental Bronchopulmonary Dysplasia and Restore Lung Function through Macrophage Immunomodulation.
    Willis GR; Fernandez-Gonzalez A; Anastas J; Vitali SH; Liu X; Ericsson M; Kwong A; Mitsialis SA; Kourembanas S
    Am J Respir Crit Care Med; 2018 Jan; 197(1):104-116. PubMed ID: 28853608
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhibition of β-catenin signaling improves alveolarization and reduces pulmonary hypertension in experimental bronchopulmonary dysplasia.
    Alapati D; Rong M; Chen S; Hehre D; Hummler SC; Wu S
    Am J Respir Cell Mol Biol; 2014 Jul; 51(1):104-13. PubMed ID: 24484510
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparative Effects of Bone Marrow-derived Versus Umbilical Cord Tissue Mesenchymal Stem Cells in an Experimental Model of Bronchopulmonary Dysplasia.
    Benny M; Courchia B; Shrager S; Sharma M; Chen P; Duara J; Valasaki K; Bellio MA; Damianos A; Huang J; Zambrano R; Schmidt A; Wu S; Velazquez OC; Hare JM; Khan A; Young KC
    Stem Cells Transl Med; 2022 Mar; 11(2):189-199. PubMed ID: 35298658
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Human Umbilical Cord Mesenchymal Stem Cell-Derived Small Extracellular Vesicles Alleviate Lung Injury in Rat Model of Bronchopulmonary Dysplasia by Affecting Cell Survival and Angiogenesis.
    You J; Zhou O; Liu J; Zou W; Zhang L; Tian D; Dai J; Luo Z; Liu E; Fu Z; Zou L
    Stem Cells Dev; 2020 Dec; 29(23):1520-1532. PubMed ID: 33040709
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Adipose Stem Cells Derived Exosomes Alleviate Bronchopulmonary Dysplasia and Regulate Autophagy in Neonatal Rats.
    Sun Y; Chen C; Liu Y; Sheng A; Wang S; Zhang X; Wang D; Wang Q; Lu C; Lin Z
    Curr Stem Cell Res Ther; 2024; 19(6):919-932. PubMed ID: 37817518
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Heparin improves alveolarization and vascular development in hyperoxia-induced bronchopulmonary dysplasia by inhibiting neutrophil extracellular traps.
    Sun Y; Chen C; Zhang X; Wang S; Zhu R; Zhou A; Chen S; Feng J
    Biochem Biophys Res Commun; 2020 Jan; 522(1):33-39. PubMed ID: 31735330
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Intratracheal administration of mesenchymal stem cell-derived extracellular vesicles reduces lung injuries in a chronic rat model of bronchopulmonary dysplasia.
    Porzionato A; Zaramella P; Dedja A; Guidolin D; Bonadies L; Macchi V; Pozzobon M; Jurga M; Perilongo G; De Caro R; Baraldi E; Muraca M
    Am J Physiol Lung Cell Mol Physiol; 2021 May; 320(5):L688-L704. PubMed ID: 33502939
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Upregulation of Vascular Endothelial Growth Factor in Amniotic Fluid Stem Cells Enhances Their Potential to Attenuate Lung Injury in a Preterm Rabbit Model of Bronchopulmonary Dysplasia.
    Jiménez J; Lesage F; Richter J; Nagatomo T; Salaets T; Zia S; Mori Da Cunha MG; Vanoirbeek J; Deprest JA; Toelen J
    Neonatology; 2018; 113(3):275-285. PubMed ID: 29393249
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Preconditioning enhances the paracrine effect of mesenchymal stem cells in preventing oxygen-induced neonatal lung injury in rats.
    Waszak P; Alphonse R; Vadivel A; Ionescu L; Eaton F; Thébaud B
    Stem Cells Dev; 2012 Oct; 21(15):2789-97. PubMed ID: 22533467
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Intra-tracheal administration of a naked plasmid expressing stromal derived factor-1 improves lung structure in rodents with experimental bronchopulmonary dysplasia.
    Guerra K; Bryan C; Dapaah-Siakwan F; Sammour I; Drummond S; Zambrano R; Chen P; Huang J; Sharma M; Shrager S; Benny M; Wu S; Young KC
    Respir Res; 2019 Nov; 20(1):255. PubMed ID: 31718614
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Reduced platelet-derived growth factor receptor expression is a primary feature of human bronchopulmonary dysplasia.
    Popova AP; Bentley JK; Cui TX; Richardson MN; Linn MJ; Lei J; Chen Q; Goldsmith AM; Pryhuber GS; Hershenson MB
    Am J Physiol Lung Cell Mol Physiol; 2014 Aug; 307(3):L231-9. PubMed ID: 24907056
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mesenchymal stem cells protect against neonatal rat hyperoxic lung injury.
    Zhang H; Fang J; Wu Y; Mai Y; Lai W; Su H
    Expert Opin Biol Ther; 2013 Jun; 13(6):817-29. PubMed ID: 23534609
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Recombinant CCN1 prevents hyperoxia-induced lung injury in neonatal rats.
    Vaidya R; Zambrano R; Hummler JK; Luo S; Duncan MR; Young K; Lau LF; Wu S
    Pediatr Res; 2017 Nov; 82(5):863-871. PubMed ID: 28700567
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cell type-dependent variation in paracrine potency determines therapeutic efficacy against neonatal hyperoxic lung injury.
    Ahn SY; Chang YS; Sung DK; Yoo HS; Sung SI; Choi SJ; Park WS
    Cytotherapy; 2015 Aug; 17(8):1025-35. PubMed ID: 25863963
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Bronchioalveolar stem cells increase after mesenchymal stromal cell treatment in a mouse model of bronchopulmonary dysplasia.
    Tropea KA; Leder E; Aslam M; Lau AN; Raiser DM; Lee JH; Balasubramaniam V; Fredenburgh LE; Alex Mitsialis S; Kourembanas S; Kim CF
    Am J Physiol Lung Cell Mol Physiol; 2012 May; 302(9):L829-37. PubMed ID: 22328358
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sildenafil alleviates bronchopulmonary dysplasia in neonatal rats by activating the hypoxia-inducible factor signaling pathway.
    Park HS; Park JW; Kim HJ; Choi CW; Lee HJ; Kim BI; Chun YS
    Am J Respir Cell Mol Biol; 2013 Jan; 48(1):105-13. PubMed ID: 23065129
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.